Innovative Precision Medicine OneOme specializes in pharmacogenomics solutions that enable healthcare providers to deliver personalized medication plans, presenting opportunities to partner with hospitals, clinics, and insurance payers seeking to improve patient outcomes and reduce prescription costs.

Growing Industry Recognition Recognized by Fast Company as one of the most innovative companies and with expanding partnerships like Tabula Rasa Healthcare and Azova, OneOme is gaining visibility in the healthcare technology space, which can facilitate introductions to broader healthcare networks and potential clients.

Technologically Advanced Offerings With its CLIA-certified lab and continuously updating genetic testing capabilities, including expanding gene and medication panels, OneOme offers scalable and cutting-edge solutions adaptable for healthcare organizations looking to enhance their pharmacogenomics services.

Market Potential and Revenue With a revenue range of 10 to 25 million and an innovative product pipeline, OneOme represents a promising target for investment, strategic alliances, or value-added reselling agreements to expand market reach and accelerate revenue growth in the personalized medicine sector.